latest news stock values companies glp-1 obesity cardiometabolic The rate in the US fell in 2023 as GLP-1s go mainstream Eli Lilly Expands Obesity Access

Participants taking semaglutide or tirzepatide reported significantly lower alcohol intake, fewer drinks per episode, and lower binge drinking odds compared to before starting medication

Review articles must distinguish clearly between established evidence, emerging hypotheses, and speculative opportunities

Vid tangentbordet -Carl-Magnus

Advocacy groups and grieving parents continue to call for stronger safeguards to prevent what they describe as a digital drug market targeting young users

Its just part of your body getting used to the new routine

Back Trapp, S, Brierley, DI (29 July 2021) 'Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment' British Journal of Pharmacology